Position in PFE
as of Jun 30, 2026
· filed Jul 9, 2026
Position Value
$1,332,755
-$176,488 QoQ
Shares Held
55,347
+3.0% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#1,155
of 2,821 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Procyon Advisors, LLC holds $38,982,476 across 11 Drug Manufacturers - General names. PFE ranks #7 (3.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
32,392 | $8,151,122 | |
| 2 | JNJ |
Johnson & Johnson
|
30,495 | $7,744,815 | |
| 3 | LLY |
ELI LILLY & Co
|
6,408 | $7,685,948 | |
| 4 | MRK |
Merck & Co., Inc.
|
50,916 | $6,542,706 | |
| 5 | AMGN |
Amgen Inc
|
6,850 | $2,480,522 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
17,103 | $2,160,793 | |
| 7 | PFE |
Pfizer Inc
This page
|
55,347 | $1,332,755 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
16,718 | $963,291 |
All Filings in PFE
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,332,755 | 55,347 | Shares | Sole | 2026-07-09 | |
| 2026-03-31 | $1,509,243 | 53,748 | Shares | Sole | 2026-05-04 | |
| 2025-12-31 | $1,328,116 | 53,338 | Shares | Sole | 2026-01-07 | |
| 2025-09-30 | $1,494,733 | 58,663 | Shares | Sole | 2025-10-28 | |
| 2025-06-30 | $1,422,791 | 58,696 | Shares | Sole | 2025-07-09 | |
| 2025-03-31 | $1,991,495 | 78,591 | Shares | Sole | 2025-04-11 | |
| 2024-12-31 | $1,474,298 | 55,571 | Shares | Sole | 2025-01-15 | |
| 2024-09-30 | $1,624,894 | 56,147 | Shares | Sole | 2024-10-11 | |
| 2024-06-30 | $1,561,787 | 55,818 | Shares | Sole | 2024-08-02 | |
| 2024-03-31 | $1,637,250 | 59,000 | Shares | Sole | 2024-04-15 | |
| 2023-12-31 | $1,788,175 | 62,111 | Shares | Sole | 2024-01-18 | |
| 2023-09-30 | $2,608,322 | 78,635 | Shares | Sole | 2023-10-10 | |
| 2023-06-30 | $1,666,702 | 45,439 | Shares | Sole | 2023-07-17 | |
| 2023-03-31 | $1,260,148 | 30,886 | Shares | Sole | 2023-04-10 | |
| 2022-12-31 | $1,450,809 | 28,314 | Shares | Sole | 2023-01-19 | |
| 2022-09-30 | $999,916 | 22,850 | Shares | Sole | 2022-10-17 | |
| 2022-06-30 | $1,299,687 | 24,789 | Shares | Sole | 2022-07-11 | |
| 2022-03-31 | $1,434,960 | 27,718 | Shares | Sole | 2022-04-18 | |
| 2021-12-31 | $1,617,556 | 27,393 | Shares | Sole | 2022-01-18 | |
| 2021-09-30 | $1,283,848 | 29,850 | Shares | Sole | 2021-10-14 | |
| 2021-06-30 | $1,509,148 | 38,538 | Shares | Sole | 2021-07-22 | |
| 2021-03-31 | $565,260 | 15,602 | Shares | Sole | 2021-04-29 | |
| 2020-12-31 | $582,039 | 15,812 | Shares | Sole | 2021-01-19 | |
| 2020-09-30 | $502,385 | 13,689 | Shares | Sole | 2020-10-22 | |
| 2020-06-30 | $386,645 | 11,824 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $339,553 | 10,403 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||